Racial/ethnic differences in treatment recommendations: lifestyle changes and medication prescriptions for high

Emily Bacon1

  • 1Department of Sociology and Population Program, Institute of Behavioral Science, University of Colorado Boulder, Boulder, CO, USA.

Ethnicity & Health
|November 3, 2017
PubMed

Insights

Racial and ethnic disparities exist in high cholesterol treatment. Non-Hispanic Black and Hispanic patients received more lifestyle change advice, but fewer medication prescriptions, indicating potential discrimination.

Area of Science:

  • Cardiovascular Disease
  • Health Disparities
  • Medical Treatment

Background:

  • High cholesterol affects nearly one third of US adults and is a precursor to coronary heart disease.
  • Understanding race/ethnic differences in treatment is crucial for equitable care.

Purpose of the Study:

  • To investigate race/ethnic disparities in treatment recommendations for high cholesterol.
  • Examined differences in lifestyle change advice and prescription medication.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (NHANES) and National Ambulatory Medical Care Survey (NAMCS).
  • Employed logistic regression analyses, adjusting for demographic, socioeconomic, and health-related factors.
  • Analyzed treatment recommendations by patient race/ethnicity and age.

Main Results:

  • Non-Hispanic Black and Hispanic patients were more likely to receive lifestyle change recommendations than non-Hispanic White patients.
  • These disparities were more pronounced in younger adults and diminished in those over 65.
  • Non-Hispanic Black patients received fewer cholesterol-lowering medication prescriptions compared to non-Hispanic White patients, especially younger individuals.

Conclusions:

  • Significant race/ethnic differences exist in high cholesterol treatment recommendations.
  • Disparities in lifestyle advice, not prescription practices, may indicate discrimination.
  • Increased provider education on effective treatment is recommended to address these inequities.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
744
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.6K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
330